India Glycols Limited
INDIAGLYCO.NS
National Stock Exchange of India1,067.75
INR
+25.05
- -
India Glycols Limited
INDIAGLYCO.NS
(National Stock Exchange of India)
Recent
price
1,067.75
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- India Glycols Limited, founded in 1983 and headquartered in Noida, India, operates as a leading green technology specialty chemical company with a diversified portfolio spanning four main segments: bio-based specialties and performance chemicals, potable spirits, Ennature biopharma, and industrial gases. Its core products include bio-based mono ethylene glycol (MEG), di ethylene glycol (DEG), tri ethylene glycol (TEG), glycol ethers, ethoxylates utilized in paints, textiles, pharmaceuticals, and packaging; high-grade extra neutral alcohol (ENA) and Indian made foreign liquor (IMFL) in the potable spirits segment; plant-based active pharmaceutical ingredients (APIs), nutraceutical products, and botanical extracts under the Ennature Biopharma brand; and industrial gases such as liquid oxygen, nitrogen, argon, and carbon dioxide for medical and industrial applications. The company produces over 100 green products driven by renewable raw materials like molasses and bioethanol, with a global export footprint to more than 40 countries. In recent years, India Glycols has focused on expanding its biofuel and ethanol production capacity, aiming to reach 1,070 kiloliters per day by FY25, up from 350 kiloliters per day in FY23, as part of its sustainable growth strategy in renewable fuels and green chemicals. The company has partially commissioned Phase II of its expansion project for value-added chemical products with an expected capacity increase of approximately 5,000 metric tons per year. It has enhanced its operational model by reducing dependence on imported raw materials, improving margins and achieving incremental capacity expansions in select areas. India Glycols also maintains a strategic joint venture with Clariant AG, "Clariant IGL Specialty Chemicals Pvt. Ltd.," which advances the production of renewable ethylene oxide derivatives targeting personal and home care markets. Furthermore, the company is upgrading its nutraceutical facilities to meet regulated markets in the US and Europe and is pursuing new geographic markets and product innovations, particularly in the specialty and performance chemical verticals. India Glycols operates primarily in the chemicals industry under the materials sector, serving broad end-user markets including pharmaceuticals, healthcare, textiles, automotive, personal care, food and beverage, paints and coatings, oil and gas, and packaging industries. It holds a significant presence in the Indian market with ongoing efforts to enhance global competitiveness through green chemistry and bio-based innovations. The company is led by CEO Rupark Sarswat and continues to implement modular manufacturing expansions at its Kashipur facility, emphasizing sustainability with zero liquid discharge plants and renewable feedstocks as foundational elements of its business approach. Overall, India Glycols transitions from commodity chemicals to higher-margin specialty products while capitalizing on trends in sustainability, biofuels, and green technology chemicals to drive long-term growth.